(Q38000961)

26 August 2017

Prostate cancer and immunoproteome: awakening and reprogramming the guardian angels (English)

1 reference

26 August 2017

1 reference

Ammad Ahmad Farooqi

1

1 reference

26 August 2017

Sundas Fayyaz

series ordinal

2

1 reference

26 August 2017

Muhammad Zahid Qureshi

series ordinal

3

1 reference

26 August 2017

Sadia Rashid

series ordinal

4

1 reference

26 August 2017

8 April 2012

1 reference

Archivum Immunologiae et Therapiae Experimentalis

26 August 2017

1 reference

26 August 2017

60

1 reference

26 August 2017

191-198

1 reference

26 August 2017

3

1 reference

https://scigraph.springernature.com/pub.10.1007/s00005-012-0169-y

26 August 2017

0 references

cites work

DNAM-1 ligand expression on Ag-stimulated T lymphocytes is mediated by ROS-dependent activation of DNA-damage response: relevance for NK-T cell interaction

1 reference

https://api.crossref.org/works/10.1007%2FS00005-012-0169-Y

Proteasome regulation of ULBP1 transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-012-0169-Y

Targeting cell surface β2 -microglobulin by pentameric IgM antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-012-0169-Y

The use of chelated radionuclide (samarium-153-ethylenediaminetetramethylenephosphonate) to modulate phenotype of tumor cells and enhance T cell-mediated killing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-012-0169-Y

Differential CTLs specific for prostate-specific antigen in healthy donors and patients with prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-012-0169-Y

Targeting TARP, a novel breast and prostate tumor-associated antigen, with T cell receptor-like human recombinant antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-012-0169-Y

Effective targeting of prostate cancer by lymphocytes redirected by a PSMA × CD3 bispecific single-chain diabody.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-012-0169-Y

Bacillus Calmette-Guérin cell-wall skeleton enhances the killing activity of cytotoxic lymphocyte-activated human dendritic cells transduced with the prostate-specific antigen gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-012-0169-Y

NKG2D-deficient mice are defective in tumor surveillance in models of spontaneous malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-012-0169-Y

Induction of in vitro and in vivo NK cell cytotoxicity using high-avidity immunoligands targeting prostate-specific membrane antigen in prostate carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-012-0169-Y

Lactobacilli secreting a tumor antigen and IL15 activates neutrophils and dendritic cells and generates cytotoxic T lymphocytes against cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-012-0169-Y

Vaccination with recombinant adenoviruses and dendritic cells expressing prostate-specific antigens is effective in eliciting CTL and suppresses tumor growth in the experimental prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-012-0169-Y

Cutting edge: permissive MHC class II allele changes the pattern of antitumor immune response resulting in failure of tumor rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-012-0169-Y

Recognition of prostate and melanoma tumor cells by six-transmembrane epithelial antigen of prostate-specific helper T lymphocytes in a human leukocyte antigen class II-restricted manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-012-0169-Y

Anti-tumor immune response induced by dendritic cells transduced with truncated PSMA IRES 4-1BBL recombinant adenoviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-012-0169-Y

Development of an MHC class I L(d)-restricted PSA peptide-loaded tetramer for detection of PSA-specific CD8+ T cells in the mouse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-012-0169-Y

Pharmacological activation of p53 triggers anticancer innate immune response through induction of ULBP2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-012-0169-Y

Hydroxyurea upregulates NKG2D ligand expression in myeloid leukemia cells synergistically with valproic acid and potentially enhances susceptibility of leukemic cells to natural killer cell-mediated cytolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-012-0169-Y

Generation of robust cytotoxic T lymphocytes against prostate specific antigen by transduction of dendritic cells using protein and recombinant adeno-associated virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-012-0169-Y

SIGLEC12, a human-specific segregating (pseudo)gene, encodes a signaling molecule expressed in prostate carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-012-0169-Y

MHC class I and class II molecules are expressed in both human and mouse prostate tumor microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-012-0169-Y

Tumor cells infected with oncolytic influenza A virus prime natural killer cells for lysis of resistant tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-012-0169-Y

Targeting 4-1BB costimulation to disseminated tumor lesions with bi-specific oligonucleotide aptamers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-012-0169-Y

Attenuation of the glucocorticoid response during Ad5IL-12 adenovirus vector treatment enhances natural killer cell-mediated killing of MHC class I-negative LNCaP prostate tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-012-0169-Y

Recognition of six-transmembrane epithelial antigen of the prostate-expressing tumor cells by peptide antigen-induced cytotoxic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-012-0169-Y

Expression and immunotherapeutic targeting of the SSX family of cancer-testis antigens in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-012-0169-Y

ATM-ATR-dependent up-regulation of DNAM-1 and NKG2D ligands on multiple myeloma cells by therapeutic agents results in enhanced NK-cell susceptibility and is associated with a senescent phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-012-0169-Y

Tumor growth and metastasis suppression by Glipr1 gene-modified macrophages in a metastatic prostate cancer model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-012-0169-Y

Induction of MHC class I-related chain B (MICB) by 5-aza-2'-deoxycytidine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-012-0169-Y

Decreased Dicer expression elicits DNA damage and up-regulation of MICA and MICB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-012-0169-Y

Tumor specific cytotoxicity and telomerase down-regulation in prostate cancer by autologous dendritic cells loaded with whole tumor cell antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-012-0169-Y

Enhanced therapeutic efficacy of IL-12, but not GM-CSF, expressing oncolytic herpes simplex virus for transgenic mouse derived prostate cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-012-0169-Y

DNA fusion gene vaccines induce cytotoxic T-cell attack on naturally processed peptides of human prostate-specific membrane antigen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-012-0169-Y

Dendritic cell-based multi-epitope immunotherapy of hormone-refractory prostate carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-012-0169-Y

Obstructing shedding of the immunostimulatory MHC class I chain-related gene B prevents tumor formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-012-0169-Y

Vaccination with a DNA vaccine based on human PSCA and HSP70 adjuvant enhances the antigen-specific CD8+ T-cell response and inhibits the PSCA+ tumors growth in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-012-0169-Y

10.1007/S00005-012-0169-Y

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

26 August 2017

0 references

1 reference